Selected article for: "case report and moderate patient"

Author: Gottardi, Andrea De; Fratila, Corneliu; Bertoli, Raffaela; Cerny, Andreas; Magenta, Lorenzo; Gianella, Pietro; Majno-Hurst, Pietro; Ceschi, Alessandro; Vanini, Gianluca; Bernasconi, Enos
Title: Clinical characteristics and management of a liver transplanted patient admitted with SARS-CoV-2 infection
  • Cord-id: 9ixq8hwb
  • Document date: 2020_6_10
  • ID: 9ixq8hwb
    Snippet: SUMMARY We present here the case of a 62-year-old man, who was referred to the emergency department with fever and cough for 3 days. He underwent liver transplantation 4 years earlier due to HCV and NASH-related cirrhosis with hepatocellular carcinoma. At admission he was in reduced general conditions. Nasopharyngeal smear specimen resulted positive for SARS-CoV-2 infection. Pulmonary low-dose CT-scan revealed bilateral subpleural ground-glass infiltrates. O2 saturation was 93%. A treatment with
    Document: SUMMARY We present here the case of a 62-year-old man, who was referred to the emergency department with fever and cough for 3 days. He underwent liver transplantation 4 years earlier due to HCV and NASH-related cirrhosis with hepatocellular carcinoma. At admission he was in reduced general conditions. Nasopharyngeal smear specimen resulted positive for SARS-CoV-2 infection. Pulmonary low-dose CT-scan revealed bilateral subpleural ground-glass infiltrates. O2 saturation was 93%. A treatment with lopinavir/ritonavir and hydroxychloroquine twice daily was started. The patient received also cefepime and remained in isolation. Seven days later imaging showed a progression of the pulmonary infiltrates. Cefepime was replaced by meropenem. During the following 3 days the fever resolved, and the general conditions of the patient significantly improved. Consequently, treatment with lopinavir/ritonavir and hydroxychloroquine was stopped. The evolution of SARS-CoV-2 interstitial pneumonia in this immunosuppressed patient was moderate to severe and liver injury was not clinically significant. Despite its limitations, this case report confirm that the liver may be only mildly affected during SARS-CoV-2 infection, also in liver transplanted patients. Further studies are needed to assess whether the outcome of SARS-CoV-2 infection is worse in immunosuppressed patients than in the general population.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory distress syndrome and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • acute respiratory distress syndrome and liver function test: 1, 2
    • acute respiratory distress syndrome and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and liver severe: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • acute respiratory distress syndrome and liver severe injury: 1, 2, 3, 4, 5
    • acute respiratory distress syndrome and liver severe injury moderate: 1
    • acute respiratory distress syndrome and liver transplant: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory distress syndrome and liver transplant patient: 1
    • acute respiratory distress syndrome and liver transplantation: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and lopinavir ritonavir treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • acute respiratory distress syndrome and lopinavir treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • acute respiratory distress syndrome respiratory failure and liver severe: 1
    • acute respiratory distress syndrome respiratory failure and lopinavir ritonavir: 1
    • acute respiratory distress syndrome respiratory failure and lopinavir ritonavir treatment: 1
    • acute respiratory distress syndrome respiratory failure and lopinavir treatment: 1
    • admission increase and liver function: 1, 2, 3
    • admission increase and liver injury: 1
    • admission increase and liver severe: 1